Latest Investment News

Kingston Resources reported a 14% increase in quarterly revenue to $18.1 million despite a geotechnical setback, while underground mining development gains momentum and resource estimates grow by 29%.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Fortescue Metals Group has delivered a record first half FY26 iron ore shipment of 100.2 million tonnes, alongside key progress in decarbonisation and strategic copper acquisition.

West Wits Mining has upsized its institutional placement to A$33.74 million, anchored by a $10 million strategic investment from Tribeca Investment Partners, fully funding the Qala Shallows project ahead of first gold pour in March 2026.

Pantoro Gold delivered a solid December quarter with strong gold production, robust EBITDA, and promising exploration results at its Norseman Gold Project.

Fenix Resources has reported record iron ore shipments and updated its FY26 guidance, unveiling ambitious plans to expand production to 10 million tonnes per annum by 2031 while extending mine life to 2042.

Sandfire Resources reported solid H1 FY26 production with a shift toward stronger H2 volumes, improved safety metrics, and a strategic move to acquire an 80% stake in the Kalkaroo Copper-Gold Project.

Resolute Mining capped 2025 with robust gold production and a strong cash position, unveiling a major update to its Doropo project that underpins ambitious growth plans targeting over 500,000 ounces annually by 2028.

Insignia Financial’s Funds Under Management and Administration edged up to $342 billion, driven by strong inflows into its Wrap platform and multi-asset solutions, while Master Trust funds faced ongoing outflows amid product transitions.

Resolute Mining reported solid 2025 production and financial results, underpinned by strategic project developments in West Africa. The company’s updated Doropo feasibility study and robust cash position set the stage for significant growth in 2026.

Cogstate Ltd has reported a remarkable 105% surge in clinical trial sales contracts for the first half of 2026, surpassing revenue guidance and signalling a more diversified and resilient business model.

South32 maintains its FY26 production guidance across operated assets while advancing key projects like Hermosa and navigating the upcoming Mozal Aluminium care and maintenance phase.